FEVASTIN
Main information
- Trade name:
- FEVASTIN 60ML SYR
- Active ingredient:
- Paracetamol
- Available from:
- TABLETS I.
- Dosage:
- 125MG/5ML
- Pharmaceutical form:
- SYR
- Composition:
- 60ML
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
1-2-2018
Scientific guideline: Paracetamol oral use immediate release formulations product-specific bioequivalence guidance - First version, adopted
This document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol.
Europe - EFSA - European Food Safety Authority EFSA Journal
1-2-2018
Scientific guideline: Overview of comments received on 'Paracetamol oral use, immediate release formulations product-specific bioequivalence guidance' (EMA/CHMP/356877/2017) - First version
Europe - EFSA - European Food Safety Authority EFSA Journal
16-1-2018
Yunnan Feng Shi Ling capsules – counterfeit
Yunnan Feng Shi Ling capsules contain the undeclared substance paracetamol.
Therapeutic Goods Administration - Australia
27-2-2014
Paracetamol use during pregnancy
A new Danish study suggests a possible connection between mothers' use of paracetamol painkillers during pregnancy and the risk of developing disorders like ADHD (attention deficit hyperactivity disorder) in children.
Danish Medicines Agency
3-8-2012
Danish Pharmacovigilance Update, 21 June 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.
Danish Medicines Agency
15-12-2017
News and press releases: Modified-release paracetamol-containing products to be suspended from EU market
Recommendation endorsed due to the difficulty in managing overdose
Europe - EMA - European Medicines Agency
8-8-2017
Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb)
Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb) (Active substance: paracetamol / ibuprofen) - Community Referrals - Art 29 - Commission Decision (2017) 5646 of Tue, 08 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1447
Europe -DG Health and Food Safety
28-7-2017
Scientific guideline: Draft paracetamol oral use, immediate release formulations product-specific bioequivalence guidance - First version, draft: consultation open
This document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol
Europe - EMA - European Medicines Agency